Affinity chromatography media, MabSelect™ PrismA
MabSelect™ PrismA, Liquid, 60 µm, 200 ml
Katalognr. 17-5498-02
Anbieter: Cytiva
Direkt zu
Product Details & Documents
MabSelect™ PrismA has been improved with an optimised high-flow agarose base matrix and a genetically engineered protein A-derived ligand, allowing future demands in mAb processing to be met.
- Enhanced dynamic binding capacity allows high mass throughput of processed mAb per resin volume unit
- Excellent alkaline stability enables efficient cleaning and sanitisation using 0,5 to 1,0 M NaOH for improved process economy, bioburden, control and robustness
- Covered by a comprehensive security of supply program, including dual sources of the agarose base matrix and protein A ligand
MabSelect™ PrismA builds on the proven track record of MabSelect™ and MabSelect™ SuRe™ resins in commercial mAb production.
Dokumente
Cytiva CyDye Licensing Statements Cytiva General Licensing Statements
Weitere Produktdetails
Technische Daten
Technische Daten
- Partikelgröße:60 µm
- VE:200 ml
- Bezeichnung:MabSelect™ PrismA
- Typ:Liquid
- Cat. No.:17-5498-02
- Lagertemperatur:2 - 8 °C
- pH-Bereich:3 – 12
- Matrix:Rigid, highly cross-linked agarose
- Ligand:Alkaline-stabilised protein A-derived (E.coli)
- Bindungskapazität:~ 40 mg polyclonal IgG/ml resin, 2 min residence time<br />~ 80 mg polyclonal IgG/ml resin, 6 min residence time
- Methode der Ligandenkupplung:Epoxy
Technische Daten
Consigli
I suggerimenti saranno personalizzati in base alle tue preferenze di acquisto solo se hai attivato "Migliora la mia esperienza di acquisto" nella pagina "Informazioni personali".
Altrimenti riceverai suggerimenti generici..



